View in EDS

1176P Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)

Saved in:
Bibliographic Details
Title: 1176P Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)
Authors: Vansteenkiste, J.F.1 (AUTHOR), Demedts, I.2 (AUTHOR), Pons-Tostivint, E.3 (AUTHOR), Biesma, B.4 (AUTHOR), Borm, F.5 (AUTHOR), Colinet, B.6 (AUTHOR), Cuppens, K.7 (AUTHOR), Derijcke, S.8 (AUTHOR), Greillier, L.9 (AUTHOR), Jürgens, J.10 (AUTHOR), Moro-Sibilot, D.11 (AUTHOR), Pérol, M.12 (AUTHOR), Sebastian, M.13 (AUTHOR), Skrzypski, M.14 (AUTHOR), Theelen, W.15 (AUTHOR), Van De Kerkhove, C.16 (AUTHOR), Collodoro, M.17 (AUTHOR), Plumas, J.18 (AUTHOR), Debruyne, C.19 (AUTHOR), Sibille, A.20 (AUTHOR)
Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1086-S1086. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 159078083
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1176P Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Vansteenkiste%2C+J%2EF%2E%22">Vansteenkiste, J.F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Demedts%2C+I%2E%22">Demedts, I.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pons-Tostivint%2C+E%2E%22">Pons-Tostivint, E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Biesma%2C+B%2E%22">Biesma, B.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Borm%2C+F%2E%22">Borm, F.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Colinet%2C+B%2E%22">Colinet, B.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cuppens%2C+K%2E%22">Cuppens, K.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Derijcke%2C+S%2E%22">Derijcke, S.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Greillier%2C+L%2E%22">Greillier, L.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jürgens%2C+J%2E%22">Jürgens, J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moro-Sibilot%2C+D%2E%22">Moro-Sibilot, D.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pérol%2C+M%2E%22">Pérol, M.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sebastian%2C+M%2E%22">Sebastian, M.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Skrzypski%2C+M%2E%22">Skrzypski, M.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Theelen%2C+W%2E%22">Theelen, W.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Van+De+Kerkhove%2C+C%2E%22">Van De Kerkhove, C.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Collodoro%2C+M%2E%22">Collodoro, M.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Plumas%2C+J%2E%22">Plumas, J.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Debruyne%2C+C%2E%22">Debruyne, C.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sibille%2C+A%2E%22">Sibille, A.</searchLink><relatesTo>20</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2022 Supplement 7, Vol. 33, pS1086-S1086. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159078083
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2022.07.1299
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S1086
    Titles:
      – TitleFull: 1176P Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vansteenkiste, J.F.
      – PersonEntity:
          Name:
            NameFull: Demedts, I.
      – PersonEntity:
          Name:
            NameFull: Pons-Tostivint, E.
      – PersonEntity:
          Name:
            NameFull: Biesma, B.
      – PersonEntity:
          Name:
            NameFull: Borm, F.
      – PersonEntity:
          Name:
            NameFull: Colinet, B.
      – PersonEntity:
          Name:
            NameFull: Cuppens, K.
      – PersonEntity:
          Name:
            NameFull: Derijcke, S.
      – PersonEntity:
          Name:
            NameFull: Greillier, L.
      – PersonEntity:
          Name:
            NameFull: Jürgens, J.
      – PersonEntity:
          Name:
            NameFull: Moro-Sibilot, D.
      – PersonEntity:
          Name:
            NameFull: Pérol, M.
      – PersonEntity:
          Name:
            NameFull: Sebastian, M.
      – PersonEntity:
          Name:
            NameFull: Skrzypski, M.
      – PersonEntity:
          Name:
            NameFull: Theelen, W.
      – PersonEntity:
          Name:
            NameFull: Van De Kerkhove, C.
      – PersonEntity:
          Name:
            NameFull: Collodoro, M.
      – PersonEntity:
          Name:
            NameFull: Plumas, J.
      – PersonEntity:
          Name:
            NameFull: Debruyne, C.
      – PersonEntity:
          Name:
            NameFull: Sibille, A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2022 Supplement 7
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 33
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1